Acetyl-CoA carboxylase inhibitor GS-0976 for 12 weeks reduces hepatic de novo lipogenesis and steatosis in patients with nonalcoholic steatohepatitis

Clinical Gastroenterology and Hepatology

from Gastroenterology via xlomafota13 on Inoreader https://ift.tt/2rdGvsd
via IFTTT